Molecular effects of genistein, as a potential anticancer agent, on CXCR-4 and VEGF pathway in acute lymphoblastic leukemia

被引：0
|
作者：
Mohsen Shahmoradi
Fatemeh Banisharif-Dehkordi
Mahnoush kouhihabibidehkordi
Mahdi GhatrehSamani
Mohammad-Saied Jami
Hedayatollah Shirzad
Batoul Pourgheysari
机构：
[1] Shahrekord University of Medical Sciences,Cellular and Molecular Research Center, Basic Health Sciences Institute
[2] University of California Los Angeles (UCLA),Department of Neurology, David Geffen School of Medicine
[3] Shahrekord University of Medical Sciences,Medical Plants Research Center, Basic Health Sciences Institute
来源：
Molecular Biology Reports | 2022年 / 49卷
关键词：
Acute lymphoblastic leukemia; CXCR-4; Genistein; VEGF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4161 / 4170
页数：9
相关论文
共 50 条
  • [21] Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia
    Hu, Xiufang
    Cao, Yanqin
    Yin, Xu
    Zhu, Li
    Chen, Yingyu
    Wang, Wenfeng
    Hu, Jianda
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (07) : 1362 - 1369
  • [22] CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12
    Carvalho Melo, Rita de Cassia
    Longhini, Ana Leda
    Bigarella, Carolina Louzao
    Baratti, Mariana Ozello
    Traina, Fabiola
    Favaro, Patricia
    Campos, Paula de Melo
    Olalla Saad, Sara Teresinha
    PLOS ONE, 2014, 9 (01):
  • [23] Glucocorticoids trigger a CXCR4/PLC-mediated cell survival pathway involved in resistance of B-acute lymphoblastic leukemia
    Abdoul-Azize, S.
    Vannier, J. -P.
    Guzman, M. L.
    Schneider, P.
    Boyer, O.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 452 - 453
  • [24] Molecular docking and dynamics simulation of farnesol as a potential anticancer agent targeting mTOR pathway
    Tabasum Ali
    Ifat Jan
    Rajath Ramachandran
    Rabiah Bashir
    Khurshid Iqbal Andrabi
    Ghulam Nabi Bader
    In Silico Pharmacology, 12 (2)
  • [25] CXCR-4 POSITIVE ACUTE MYELOID LEUKEMIAS (AGE < 60 YEARS) IMMUNOPHENOTYPIC, CYTOMORPHOLOGIC, CYTOGENETIC, AND MOLECULAR CHARACTERISTICS
    Oelschlaegel, U.
    Mohr, B.
    Schaekel, U.
    Kroschinsky, F.
    Schaich, M.
    Ehninger, G.
    Thiede, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 10 - 10
  • [26] Phosphorylated CXCR4 Is Associated With Poor Survival in Adults With B-Acute Lymphoblastic Leukemia
    Konoplev, Sergej
    Jorgensen, Jeffrey L.
    Thomas, Deborah A.
    Lin, E.
    Burger, Jan
    Kantarjian, Hagop M.
    Andreeff, Michael
    Medeiros, L. Jeffrey
    Konopleva, Marina
    CANCER, 2011, 117 (20) : 4689 - 4695
  • [27] Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia
    Gao, Xueliang
    Qin, Shenghui
    Wu, Yongxia
    Chu, Chen
    Jiang, Baishan
    Johnson, Roger H.
    Kuang, Dong
    Zhang, Jie
    Wang, Xi
    Mehta, Anand
    Tew, Kenneth D.
    Leone, Gustavo W.
    Yu, Xue-Zhong
    Wang, Haizhen
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (16):
  • [28] The chemokine receptor CXCR4 is essential for the maintenance of T cell acute lymphoblastic leukemia.
    Pitt, Lauren A.
    Tikhonova, Anastasia N.
    Trimarchi, Thomas
    King, Bryan
    Hu, Hai
    Gong, Yixiao
    Tsirigos, Aris
    Sanchez-Martin, Marta
    Littman, Dan R.
    Ferrando, Adolfo
    Morrison, Sean J.
    Fooksman, David R.
    Aifantis, Iannis
    Schwab, Susan
    CLINICAL CANCER RESEARCH, 2015, 21
  • [29] The prognostic value of CXCR4 and pCXCR4 in B-lineage acute lymphoblastic leukemia in adults
    Elnaggar, Amina M.
    Ghonaim, Rania A.
    El-Gohary, Tarek A.
    Atfy, Maha
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2014, 39 (03): : 128 - 133
  • [30] Role of CXCR4 and VLA-4 expression as prognostic markers in Egyptians acute lymphoblastic leukemia patients
    Elbaiomy, M. A.
    Aref, S.
    El-Ghonemy, M. Sabry
    El-Sedik, A.
    Azmy, E.
    ANNALS OF ONCOLOGY, 2015, 26 : 91 - 91
12345